Short answer
Definitive Healthcare Corp. (DH) filed its fiscal 2025 10-K annual report with the SEC on Feb 26, 2026. It reported revenue of $242M (−4.2% year over year) and net income of −$139M.
- Top risk flagged: Regulatory/legal risk: Sales tax liabilities from prior misclassification of products and services, now addressed by voluntary disclosures and registrations to avoid future penalties
FY2025 key financial metrics · XBRL
- Revenue
- $242M
- −4.2% YoY
- Net income
- −$139M
- +66.4% YoY
- Operating margin
- -92.9%
- +189.0 pp YoY
- Gross margin
- 75.9%
- −2.4 pp YoY
- EPS (diluted)
- −$1.30
- +63.3% YoY
- ROE
- -36.7%
- +31.4 pp YoY
- Operating cash flow
- $54M
- −7.6% YoY
Source: XBRL data from the Definitive Healthcare Corp. (DH) FY2025 10-K on SEC EDGAR. USD.
Definitive Healthcare Corp. FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Risk Factors
- Regulatory/legal risk: Sales tax liabilities from prior misclassification of products and services, now addressed by voluntary disclosures and registrations to avoid future penalties
- Macroeconomic/geopolitical risk: Customer churn, particularly in Life Sciences market, driven by macroeconomic headwinds and international trade/tariff uncertainties impacting spending
- Operational/supply chain risk: Disruptions in healthcare claims data market since early 2024 leading to renegotiations and potential higher acquisition costs for key data sources
- Competitive/market disruption risk: Sales execution challenges from 2024 restructuring impacting new customer acquisition and upsell, risking market position against established SaaS competitors
- Financial risk: Significant goodwill impairments over last three years totaling $1.17 billion due to sustained market capitalization declines and stock price drops
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.